Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF682 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RNASE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CD99L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VAC14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPARG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLJ35934 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC2D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDUA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB11B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on